Efficacy and safety of efsubaglutide alfa in individuals with type 2 diabetes (SUPER1): a randomised, double-blind, placebo-controlled, Phase IIb/III trial
2Citations signalées, ce qui n’est pas une note de qualité
71Institutions déclarées
3Pays d’affiliation déclarés
Rattachement africain : cn, us, tw. Niveau de preuve : code pays fourni par la source.
Résumé indisponible. Les résultats de l’étude ne doivent pas être déduits de son seul titre.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Efficacy and safety of efsubaglutide alfa in individuals with type 2 diabetes (SUPER1): a randomised, double-blind, placebo-controlled, Phase IIb/III trial
- Date Crossref
- 21/11/2025
- Éditeur
- Springer Science and Business Media LLC
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Nanjing Drum Tower HospitalSoochow UniversityFirst Affiliated Hospital of Soochow UniversityJinan Central HospitalShandong First Medical UniversityPeople's Hospital of CangzhouSecond Affiliated Hospital of Zhengzhou UniversityQingdao UniversityNanyang Institute of TechnologyAffiliated Hospital of Qingdao UniversityThe First People's Hospital of GuiyangFirst People’s Hospital of ZunyiSecond People’s Hospital of YibinJinzhou Central HospitalShanghai University of Traditional Chinese MedicineYueyang Second People's HospitalYueyang HospitalNanjing Jiangning HospitalXuzhou Medical CollegeAffiliated Hospital of Xuzhou Medical CollegeNanyang Medical CollegeHarbin Medical UniversityFourth Affiliated Hospital of Harbin Medical UniversityJiangsu UniversityAffiliated Hospital of Jiangsu UniversityFirst Affiliated Hospital of Henan University of Science and TechnologyCangzhou Central HospitalSecond Affiliated Hospital of Nanjing Medical UniversityChenzhou First People's HospitalJiangxi Pingxiang People's HospitalSecond People’s Hospital of Huai’anFlower HospitalHandan CollegeDaqing City People's HospitalThe Third People's Hospital of Dalian CityNanjing Medical UniversityDaqing Oilfield General HospitalFirst Hospital of ShijiazhuangShanxi Jincheng Anthracite Mining Group (China)Changchun Obstetrics and Gynecology HospitalChangchun 208 HospitalTongji UniversityTongji HospitalAnhui Medical UniversitySecond Affiliated Hospital of Anhui Medical UniversityYuncheng UniversityHuizhou Central People's HospitalThe First People's Hospital of ChangdeBeijing Obstetrics and Gynecology HospitalThird People's Hospital of HuzhouShanghai East HospitalJining First People's HospitalYanbian University HospitalMeiho UniversityChengdu Fifth People's HospitalFudan UniversityChongqing Three Gorges Central HospitalSecond Affiliated Hospital of Jilin UniversityHuashan HospitalChongqing Three Gorges UniversityCentral Hospital of WuhanThe First People's Hospital of ShundeSecond Hospital of Tianjin Medical UniversityTianjin Medical UniversityThe First People’s Hospital of LianyungangPudong Medical CenterPudong New Area People's HospitalFirst Affiliated Hospital of Anhui Medical UniversityHenan University Huaihe Hospital and Huaihe Clinical InstituteJiujiang UniversityFosun Pharma (China)
Une affiliation ne permet pas de déduire la nationalité d’un auteur.
Les sujets associés
Diabetes Treatment and ManagementNatural Antidiabetic Agents StudiesGinkgo biloba and Cashew Applications